1. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo
- Author
-
Yukiko Kurihara, Misako Hangaishi, Toru Aizawa, Junichi Taguchi, Minoru Ohno, Satoshi Kimura, Ryozo Nagai, and Nobukazu Ishizaka
- Subjects
Time Factors ,Systole ,Biophysics ,Ischemia ,Myocardial Ischemia ,Myocardial Reperfusion ,Myocardial Reperfusion Injury ,Pharmacology ,Biochemistry ,Gene Expression Regulation, Enzymologic ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,In vivo ,Diastole ,Heart Rate ,medicine ,Animals ,Molecular Biology ,Heme ,chemistry.chemical_classification ,Reactive oxygen species ,business.industry ,Myocardium ,Hemodynamics ,Cell Biology ,medicine.disease ,Rats ,Heme oxygenase ,Kinetics ,Enzyme ,chemistry ,Heme Oxygenase (Decyclizing) ,Hemin ,Female ,business ,Myofibroblast ,Heme Oxygenase-1 - Abstract
Enhanced production of reactive oxygen species plays a role in myocardial injury following ischemia/reperfusion. Heme oxygenase-1 (HO-1) is a heme-catabolizing enzyme that is induced by and acts against oxidant-induced tissue injury. We examined whether HO-1 expression was regulated following ischemia and reperfusion in the rat heart. HO-1 expression increased as early as 24 h after reperfusion. Strong HO-1 expression was seen in monocytes/macrophages and myofibroblasts. Next, we examined whether the induction of HO-1 could ameliorate cardiac injury following ischemia/reperfusion. Intraperitoneal hemin injection (30 mg/kg/day) for 2 days prior to the operation resulted in an about 2.8-fold increase in HO-1 expression in the rat heart. Hemin treatment significantly decreased infarct area (6 ± 2%) compared to the control (21 ± 2%), which was reversed by the coadministration of an HO inhibitor in a dose-dependent manner. Our data suggest that induction of HO-1 can reduce the cardiac injury in vivo following ischemia/reperfusion.
- Published
- 2000